Skip to content

Effect of Remote Ischemia Preconditioning on Myocardial Injury in Patients Undergoing Heart Valve Surgery

Effect of Remote Ischemia Preconditioning on Myocardial Injury in Patients Undergoing Heart Valve Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01175681
Enrollment
73
Registered
2010-08-05
Start date
2007-12-31
Completion date
2011-06-30
Last updated
2011-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Valve Diseases

Keywords

rheumatic heart disease, degenerated heart valve disease, heart valve prolapse

Brief summary

Remote ischaemic preconditioning has shown its cardiac protective effect during heart surgery including coronary artery bypass graft surgery, congenital heart disease and aneurysm. However, no data was reported on heart valve disease surgery. Rheumatic heart disease is one of the major heart diseases requiring surgery in China. Thus, the investigators chose heart valve disease as a focus to see whether remote ischaemic preconditioning also has cardiac protective effect during heart valve surgery.

Interventions

Remote ischaemic preconditioning consisted of three 5-min cycles of right upper arm ischaemia, which was induced by an automated cuff -inflator placed on the right upper arm and inflated to 200 mm Hg, with an intervening 5 min of reperfusion during which the cuff was deflated. There was a 5- to 10-min interval between completion of the remote ischaemic preconditioning protocol and initiation of bypass.Control patients had a deflated cuff placed on the right upper arm for 30 min.

Sponsors

Guangzhou First People's Hospital
CollaboratorOTHER
Sun Yat-sen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All heart valve diseases needing heart valve surgery.

Exclusion criteria

* All four limbs existed ischemic condition

Design outcomes

Primary

MeasureTime frameDescription
plasma troponin I levelwith 7 days after surgeryThe investigators will measure the plasma troponin I level in several time points before and after surgery in each patient.

Secondary

MeasureTime frame
serum creatininewithin 7 days after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026